Correlation Between Abbott Laboratories and ImpediMed

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Abbott Laboratories and ImpediMed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abbott Laboratories and ImpediMed into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abbott Laboratories and ImpediMed Limited, you can compare the effects of market volatilities on Abbott Laboratories and ImpediMed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abbott Laboratories with a short position of ImpediMed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abbott Laboratories and ImpediMed.

Diversification Opportunities for Abbott Laboratories and ImpediMed

-0.09
  Correlation Coefficient

Good diversification

The 3 months correlation between Abbott and ImpediMed is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Abbott Laboratories and ImpediMed Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ImpediMed Limited and Abbott Laboratories is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abbott Laboratories are associated (or correlated) with ImpediMed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ImpediMed Limited has no effect on the direction of Abbott Laboratories i.e., Abbott Laboratories and ImpediMed go up and down completely randomly.

Pair Corralation between Abbott Laboratories and ImpediMed

Considering the 90-day investment horizon Abbott Laboratories is expected to generate 38.2 times less return on investment than ImpediMed. But when comparing it to its historical volatility, Abbott Laboratories is 18.39 times less risky than ImpediMed. It trades about 0.03 of its potential returns per unit of risk. ImpediMed Limited is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  8.00  in ImpediMed Limited on September 12, 2024 and sell it today you would lose (3.79) from holding ImpediMed Limited or give up 47.37% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.6%
ValuesDaily Returns

Abbott Laboratories  vs.  ImpediMed Limited

 Performance 
       Timeline  
Abbott Laboratories 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Abbott Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental drivers, Abbott Laboratories is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
ImpediMed Limited 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in ImpediMed Limited are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, ImpediMed reported solid returns over the last few months and may actually be approaching a breakup point.

Abbott Laboratories and ImpediMed Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Abbott Laboratories and ImpediMed

The main advantage of trading using opposite Abbott Laboratories and ImpediMed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abbott Laboratories position performs unexpectedly, ImpediMed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ImpediMed will offset losses from the drop in ImpediMed's long position.
The idea behind Abbott Laboratories and ImpediMed Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Global Correlations
Find global opportunities by holding instruments from different markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities